ITOS: the balance sheet

MyFinsight

For the quarter ending 2025-06-30, ITOS has $623,083K in assets. $129,282K in debts. $207,820K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-06-30
Property and equipment, net	5,175
Short-term investments (amortized cost of 307,394)	307,610
Prepaid expenses and other current assets	11,015
Refundable income taxes	1,793
Grants receivable	475
Cash and cash equivalents	207,820
Research and development tax credits receivable	280
Total current assets	528,993
Restricted cash	319
Other assets	898
Right of use assets	5,129
Long-term investments (amortized cost of 74,475)	74,614
Research and development tax credits receivable, net of current portion	7,955
Total assets	623,083

Other accrued expenses	796
Lease liabilities	1,516
Accrued personnel expenses	23,774
Deferred income	1,477
Accounts payable	6,249
Accrued clinical trial costs	36,462
Total current liabilities	70,274
Unrecognized tax benefits	48,790
Lease liabilities, net of current portion	3,612
Grants repayable, net of current portion	6,606
Total liabilities	129,282
Accumulated deficit	-123,123
Common stock, 0.001 par value 150,000,000 shares authorized at march 31, 2025 and december 31, 2024 38,271,682 and 36,598,043 shares issued and outstanding, respectively	44
Additional paid-in capital	633,070
Accumulated other comprehensive loss	-16,190
Total stockholders equity	493,801
Total liabilities and stockholders equity	623,083